Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. Biomol Biomed. 2019;19(4):342-349. doi:10.17305/bjbms.2019.4136